Cargando…

Erratum to: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study

Detalles Bibliográficos
Autores principales: Peeters, Stijn A, Engelen, Lian, Buijs, Jacqueline, Chaturvedi, Nish, Fuller, John H, Schalkwijk, Casper G, Stehouwer, Coen D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587827/
https://www.ncbi.nlm.nih.gov/pubmed/26415611
http://dx.doi.org/10.1186/s12933-015-0290-4
_version_ 1782392522537959424
author Peeters, Stijn A
Engelen, Lian
Buijs, Jacqueline
Chaturvedi, Nish
Fuller, John H
Schalkwijk, Casper G
Stehouwer, Coen D
author_facet Peeters, Stijn A
Engelen, Lian
Buijs, Jacqueline
Chaturvedi, Nish
Fuller, John H
Schalkwijk, Casper G
Stehouwer, Coen D
author_sort Peeters, Stijn A
collection PubMed
description
format Online
Article
Text
id pubmed-4587827
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45878272015-09-30 Erratum to: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study Peeters, Stijn A Engelen, Lian Buijs, Jacqueline Chaturvedi, Nish Fuller, John H Schalkwijk, Casper G Stehouwer, Coen D Cardiovasc Diabetol Erratum BioMed Central 2015-09-28 /pmc/articles/PMC4587827/ /pubmed/26415611 http://dx.doi.org/10.1186/s12933-015-0290-4 Text en © Peeters et al. 2015 This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Erratum
Peeters, Stijn A
Engelen, Lian
Buijs, Jacqueline
Chaturvedi, Nish
Fuller, John H
Schalkwijk, Casper G
Stehouwer, Coen D
Erratum to: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study
title Erratum to: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study
title_full Erratum to: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study
title_fullStr Erratum to: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study
title_full_unstemmed Erratum to: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study
title_short Erratum to: Plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the EURODIAB Prospective Complications Study
title_sort erratum to: plasma levels of matrix metalloproteinase-2, -3, -10, and tissue inhibitor of metalloproteinase-1 are associated with vascular complications in patients with type 1 diabetes: the eurodiab prospective complications study
topic Erratum
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587827/
https://www.ncbi.nlm.nih.gov/pubmed/26415611
http://dx.doi.org/10.1186/s12933-015-0290-4
work_keys_str_mv AT peetersstijna erratumtoplasmalevelsofmatrixmetalloproteinase2310andtissueinhibitorofmetalloproteinase1areassociatedwithvascularcomplicationsinpatientswithtype1diabetestheeurodiabprospectivecomplicationsstudy
AT engelenlian erratumtoplasmalevelsofmatrixmetalloproteinase2310andtissueinhibitorofmetalloproteinase1areassociatedwithvascularcomplicationsinpatientswithtype1diabetestheeurodiabprospectivecomplicationsstudy
AT buijsjacqueline erratumtoplasmalevelsofmatrixmetalloproteinase2310andtissueinhibitorofmetalloproteinase1areassociatedwithvascularcomplicationsinpatientswithtype1diabetestheeurodiabprospectivecomplicationsstudy
AT chaturvedinish erratumtoplasmalevelsofmatrixmetalloproteinase2310andtissueinhibitorofmetalloproteinase1areassociatedwithvascularcomplicationsinpatientswithtype1diabetestheeurodiabprospectivecomplicationsstudy
AT fullerjohnh erratumtoplasmalevelsofmatrixmetalloproteinase2310andtissueinhibitorofmetalloproteinase1areassociatedwithvascularcomplicationsinpatientswithtype1diabetestheeurodiabprospectivecomplicationsstudy
AT schalkwijkcasperg erratumtoplasmalevelsofmatrixmetalloproteinase2310andtissueinhibitorofmetalloproteinase1areassociatedwithvascularcomplicationsinpatientswithtype1diabetestheeurodiabprospectivecomplicationsstudy
AT stehouwercoend erratumtoplasmalevelsofmatrixmetalloproteinase2310andtissueinhibitorofmetalloproteinase1areassociatedwithvascularcomplicationsinpatientswithtype1diabetestheeurodiabprospectivecomplicationsstudy
AT erratumtoplasmalevelsofmatrixmetalloproteinase2310andtissueinhibitorofmetalloproteinase1areassociatedwithvascularcomplicationsinpatientswithtype1diabetestheeurodiabprospectivecomplicationsstudy